The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
NCT03339401
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
29
Enrollment
INDUSTRY
Sponsor class
Stopped
terminated due to low enrollment rate
Conditions
Adenovirus
Interventions
OTHER:
Standard of Care
DRUG:
Brincidofovir
Sponsor
Jazz Pharmaceuticals